Walvax unit receives China regulatory approval for COVID-19 mRNA vaccine
Walvax Biotechnology Co Ltd’s unit received China regulatory approval for a COVID-19 mRNA vaccine. The company is associated with SZSE:300142.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.